Stimuli-responsive polysaccharide nanoplatforms for targeted cancer therapy

Puntos clave

• Targeted therapy with polysaccharide nanoplatforms significantly enhances drug delivery effectiveness in cancer cells.
• The study shows a marked increase in targeting accuracy, achieving a 30% improvement in therapeutic efficacy.
• Assessment involved experimental methods on cancer cell lines to evaluate drug release mechanisms.
• This finding highlights the potential for improved cancer treatments, although further clinical validation is necessary.